Porównaj metody
Przeglądaj wybrane metody obok siebie; wiersze, które się różnią, są wyróżnione.
| Brief Addiction Monitor (BAM)× | DUDIT× | |
|---|---|---|
| Dziedzina | Medycyna uzależnień | Medycyna uzależnień |
| Rodzina | Process / pipeline | Process / pipeline |
| Rok powstania≠ | 2013 | 2005 |
| Twórca≠ | Cacciola, Alterman, Drapkin, Valadez | Berman, Bergman, Palmstierna, Schlyter |
| Typ | Self-report | Self-report |
| Źródło pierwotne≠ | Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263. DOI ↗ | Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31. DOI ↗ |
| Inne nazwy | BAM | DUDIT |
| Pokrewne | 4 | 4 |
| Podsumowanie≠ | The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care. | The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings. |
| ScholarGateZbiór danych ↗ |
|
|